| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 172,320 | 202,025 | 271,669 | 240,492 | | Cost of Revenue | 142,487 | 163,613 | 194,900 | 168,163 | | | Gross Profit | 29,833 | 38,412 | 76,769 | 72,329 | | | Operating Expenses | | Research Development | 35,744 | 38,617 | 45,063 | 51,354 | | Selling General and Administrative | (749,952) | 753,821 | 50,751 | 60,678 | | Non Recurring | 800,563 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (56,522) | (754,026) | (19,045) | (39,703) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,733 | 6,316 | 2,389 | 2,508 | | Earnings Before Interest And Taxes | (44,789) | (747,710) | (16,656) | (37,195) | | Interest Expense | 2,400 | 2,501 | 2,677 | 2,587 | | Income Before Tax | (47,189) | (750,211) | (19,333) | (39,782) | | Income Tax Expense | 2,190 | 63,132 | (7,554) | (15,659) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (49,379) | (813,343) | (11,779) | (24,123) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (49,379) | (813,343) | (11,779) | (24,123) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($49,379) | ($813,343) | ($11,779) | ($24,123) |
|
1.70% Nasdaq 
Income Statement
